|
CN102068316A
|
|
Skeletal III-type malocclusion appliance
|
|
CN102451161A
|
|
Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof
|
|
CN101966181A
|
|
Oral solid preparation containing candesartan and amlodipine and new application thereof
|
|
CN101966160A
|
|
Dispersible tablet containing cefixime liposome and preparation method thereof
|
|
CN101972231A
|
|
Dry suspension containing cefixime liposome and preparation method thereof
|
|
CN101966154A
|
|
Granular formulation containing cefixime liposomes and preparation method thereof
|
|
CN101966166A
|
|
Capsule containing cefixime liposome and preparation method thereof
|
|
CN101966159A
|
|
Tablet containing cefixime liposome and preparation method thereof
|
|
CN101953791A
|
|
Capsule containing cefprozil liposome and preparation method thereof
|
|
CN101953788A
|
|
Cefprozil liposome-containing dispersible tablet and preparation method thereof
|
|
CN101953789A
|
|
Dry suspension containing cefprozil liposome and preparation method thereof
|
|
CN101953790A
|
|
Granules comprising cefprozil lipidosome and preparation method thereof
|
|
CN101953787A
|
|
Tablet containing cefprozi liposome and preparation method thereof
|
|
CN101804029A
|
|
Atorvastatin liposome and preparation method thereof, and medicine composition containing atorvastatin
|
|
CN101810580A
|
|
Valsartan liposome, preparation method thereof and medicinal composition containing same
|
|
CN102188705A
|
|
Medicament composition containing bis cyclooctane derivatives
|
|
CN102166215A
|
|
Pharmaceutical composition containing piperazine derivatives
|
|
CN102166357A
|
|
Medicinal composition containing bicyclic aza-alkane derivative
|
|
CN101810859A
|
|
Medical composition containing aniline derivative
|
|
CN101732718A
|
|
Pharmaceutical composition containing NCX inhibitors
|
